This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe
November 3–5, 2025
Vienna Congress and Convention Center, Vienna, AustriaNovember 11–12, 2025 | Digital Partnering

Thomas Lingelbach
CEO at Valneva
Speaker

Profile

Thomas Lingelbach was CEO of Intercell and founding President and CEO of Valneva. He is an established vaccine industry leader with over 30 years of experience including senior and executive management roles with Intercell, Novartis and Chiron. A German national, Thomas has successfully contributed in different capacities to the successful development and licensure of more than ten vaccines. He holds an engineering degree specialized in bioprocess engineering and completed his education with a business administration program.

Agenda Sessions

  • Tuning into the Flot.bio show - In conversation Thomas Lingelbach, Valneva

    13:00